The FDA launched real-time clinical trials with AstraZeneca and Amgen. Here’s what RTCT is, why it matters, and what it actually demands from the clinical research ecosystem.
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
- Sites Are Building Their Own Tech – SCRS On What That Means
- Human-In-The-Loop In AI Validation And Control: From Principle To Practice
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How Clinical Trial Platforms Solve Disparate Data Challenges
Disparate data systems present challenges, yet clinical trial platforms provide centralized integration, standardization, advanced analytics, and strong security for an efficient solution.
-
Webinar Recap: How EDC Can Support Modern Clinical Trials
Gain insights from our recent webinar focused on the critical role EDC systems play in supporting modern working practices and innovative trial designs, structured around four key themes.
-
Patient-Centric Clinical Trials: The Power Of Choice
Patient-centric trials, advocated by the FDA, focus on offering choices to improve engagement, diversity, and data quality. Explore how expanding patient choice can benefit clinical trials.
-
Unified Patient Apps: The Future Of Trial Simplicity
A unified patient app streamlines clinical trial participation by combining scheduling, questionnaires, travel, and payments—reducing burden, improving engagement, and supporting better retention and data quality.
-
Minimizing Hurdles For Patients During The eConsent Process
Learn how eConsent digitalizes the trial participant consent process through increasingly simplified models designed to improve comprehension and boost engagement.
-
Clinical Trials In The Age Of Cost Caps
On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.
-
Policy To Practice: PBM Reform, TrumpRx, And Global Drug Development
Policy shifts are reshaping PBM oversight, driving transparent drug‑pricing tools, and influencing global responses that affect affordability, access, and future pharma development.
-
Better eConsent Through Education Best Practices
eConsent can have a positive impact on participant retention, but learn why that is only part of the challenge of meeting participant needs in a clinical trial.
-
Want To Make Your Trial More Patient-Centric? Here's An eCOA For That
Electronic clinical outcome assessments transform the paper-based evaluation into a real-time digital tool that collects insights directly from the patient. Explore how this brings several immediate benefits.
-
EDC Selected To Support Biotech Advances In Diabetes
Find out why one leading biotechnology company keeps choosing this eClinical technologies and services provider for EDC assistance.
RECENT NEWSLETTERS
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials